Sign In
Buy CRL
$179.87
+5.08 (+2.91%)
At Close: Jun 03, 2026
Activist Elliott reaches key agreement with Charles River. Here are three ways to create value
08:49am, Saturday, 10'th May 2025
The firm has three possible paths toward value creation at the drug development company.
S&P 500 INDEX (SPX) Live: Markets Eye Potential Bullish Trend as Buying Resumes
01:00pm, Thursday, 08'th May 2025
Live Updates Live Coverage Has Ended Rates Unchanged, Stagflation Looms 2:20 pm by Gerelyn Terzo The Dow has reversed a deficit, turning a 200-point drop to a 27-point gain after the Federal Reserve k
Live Nasdaq Composite: Markets Rise on Fed Day Amid Trade Deal Hopes
01:00pm, Thursday, 08'th May 2025
Live Updates Live Coverage Has Ended GOOGL Falls 9% 2:51 pm by Gerelyn Terzo Google parent Alphabet (Nasdaq: GOOGL) stock is down a steep 9% to below $150 per share today after an Apple (Nasdaq; AAPL)
S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments
05:31pm, Wednesday, 07'th May 2025
The S&P 500 broke a two-session losing streak, rising Wednesday as stocks gained ground in volatile trading following the Federal Reserve's decision to keep interest rates unchanged.
Charles River Laboratories International, Inc. (CRL) Q1 2025 Earnings Call Transcript
02:46pm, Wednesday, 07'th May 2025
Charles River Laboratories International, Inc. (NYSE:CRL ) Q1 2025 Results Conference Call May 7, 2025 9:00 AM ET Company Participants Todd Spencer - Vice President, Investor Relations Jim Foster - Ch
Charles River Laboratories' Q1 Earnings Beat Consensus, Stock Trades Higher On Signs Of Demand Stabilization
12:39pm, Wednesday, 07'th May 2025
Charles River Laboratories International Inc CRL stock is trading higher on Wednesday after the company released better than expected first-quarter 2025 earnings.
Charles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Business Review Will Help.
12:17pm, Wednesday, 07'th May 2025
The biotech said its largest investor would conduct a ‘strategic review' as revenue continued to decline.
Top Stock Moves Now: Charles River Labs, Disney, Supermicro, and More
11:56am, Wednesday, 07'th May 2025
U.S. equities were little changed at midday as the market awaited the Federal Reserve's interest-rate decision coming this afternoon. The Dow Jones Industrial Average was higher, the Nasdaq was lower,
Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics
10:35am, Wednesday, 07'th May 2025
The headline numbers for Charles River (CRL) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street est
CRL Q1 Earnings & Revenues Beat Estimates, Stock Rises, '25 View Up
10:35am, Wednesday, 07'th May 2025
Charles River delivers better-than-expected earnings and revenues in the first quarter of 2025.
Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates
09:15am, Wednesday, 07'th May 2025
Charles River Laboratories (CRL) came out with quarterly earnings of $2.34 per share, beating the Zacks Consensus Estimate of $2.06 per share. This compares to earnings of $2.27 per share a year ago.
Charles River to add new directors, review business in agreement with Elliott
07:35am, Wednesday, 07'th May 2025
Charles River Laboratories said on Wednesday it had reached an agreement with activist investor Elliott Investment Management and added four new directors to its board.
Charles River Laboratories Announces First-Quarter 2025 Results
07:01am, Wednesday, 07'th May 2025
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Announces First-Quarter 2025 Financial Results.
Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value
07:00am, Wednesday, 07'th May 2025
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value.
Exclusive: Charles River agrees with Elliott to add new directors, review business
06:08am, Wednesday, 07'th May 2025
Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment Management to add four new directors to its board and launch a strategic review of
